Touboul, C Legendre, G Agostini, A Akladios, C Bendifallah, S Bolze, P A Bouet, P E Chauvet, P Collinet, P Dabi, Y
...
Published in
Gynecologie, obstetrique, fertilite & senologie
To draw up recommendations on the use of prophylactic gynecologic procedures during surgery for other indications. A consensus panel of 19 experts was convened. A formal conflict of interest policy was established at the onset of the process and applied throughout. The entire study was performed independently without funding from pharmaceutical com...
Hamdaoui, N Boubli, L
Published in
Gynecologie, obstetrique, fertilite & senologie
To publish, under the aegis of the French National College of Gynecologists and Obstetricians (CNGOF) and the Study Group on Menopause and Hormonal Aging (GEMVi), recommendations based on the evidence available in the literature for the management of abnormal uterine bleeding (AUB) in women taking hormonal replacement therapy (HRT). A review of the...
Nohuz, E Chêne, G Maréchal, C Atallah, A Chabert, P Michy, T Lamblin, G
Published in
Gynecologie, obstetrique, fertilite & senologie
Chene, G Lamblin, G Mezzetta, L Lablanche, O Cerruto, E Nohuz, E
Published in
Gynecologie, obstetrique, fertilite & senologie
Segerer, Sabine Elisabeth
Published in
Journal für Gynäkologische Endokrinologie/Schweiz
Blutungsstörungen in der Peri- und Postmenopause gehören zu den häufigsten Beschwerdebildern in der gynäkologischen Praxis. Sie machen ca. 70 % aller Konsultationen in dieser Altersgruppe aus. Meist sind hormonelle Dysbalancen infolge der nachlassenden ovariellen Aktivität Ursache der abnormen uterinen Blutungen (AUB) in der Perimenopause. Im Rahme...
Suárez Enríquez, José Pérez López, José Del-Carmen Martínez Hernández, Clara Magdalena
Object: To determine the concordance between hysteroscopy and histopathology in patients with abnormal uterine bleeding. Materials and methods: An observational, descriptive and cross-sectional study of 36 patients diagnosed with SUA with hysteroscopy and endometrial biopsy in the minimally invasive clinic. Results: The average age was 39.1 years w...
Dupont, Emma
Introduction : le dispositif Essure® est un moyen de stérilisation tubaire par hystéroscopie utilisé depuis 2002. En 2017, après sa mise sous surveillance par l’ANSM puis sa suspension, le laboratoire Bayer le retire du marché. Ces procédures faisaient suite à des signalements d’effets indésirables et de plaintes émanant de comités de patientes. L’...
Chene, G Lebail-Carval, K Azzi, C Chabert, P Mellier, G Lamblin, G
Published in
Gynecologie, obstetrique, fertilite & senologie
Chene, G Vidican, P Azzi, C Carval, K Lebail Chabert, P Beaufils, E Mellier, G Lamblin, G
Published in
Gynecologie, obstetrique, fertilite & senologie
Chene, G Lamblin, G
Published in
Gynecologie, obstetrique & fertilite